MiMedx Group (MDXG) Outlines 2022 Key Strategic Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. ZION
2. MMM
3. SPY
4. STLD
5. META
6. IRON
7. GRMN
8. AAPL
9. IT
10. NOW

Go back to MiMedx Group (MDXG) Outlines 2022 Key Strategic Milestones

MIMEDX Outlines Key Strategic Milestones for 2022

January 10, 2022 8:00 AM EST

MIMEDX Primed to Commence Pivotal Phase 3 Clinical Study Program of micronized dehydrated Human Amnion Chorion Membrane (mdHACM) in Knee Osteoarthritis (KOA), Targeting Potential Late-2026 Commercial Launch

Double-Digit Growth Objective in 2022 to be Driven by Treatment Transformation, Global Market Expansion and Ongoing Portfolio Innovation across Multimodal Placental Tissue Platform

Company to Present at 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12 at 5:15 PM ET

MARIETTA, Ga., Jan. 10, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), a... More